These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2173577)

  • 1. Solubilization of receptor for pituitary adenylate cyclase activating polypeptide from bovine brain.
    Masuda Y; Ohtaki T; Kitada C; Tsuda M; Arimura A; Fujino M
    Biochem Biophys Res Commun; 1990 Oct; 172(2):709-14. PubMed ID: 2173577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular structure analysis of the pituitary adenylate cyclase activating polypeptide type I receptor from pig brain.
    Cao YJ; Gimpl G; Fahrenholz F
    Biochim Biophys Acta; 1994 Jul; 1222(3):432-40. PubMed ID: 8038212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and purification of the solubilized pituitary adenylate-cyclase-activating polypeptide-1 receptor from porcine brain using a biotinylated ligand.
    Schäfer H; Schmidt WE
    Eur J Biochem; 1993 Nov; 217(3):823-30. PubMed ID: 8223638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and reconstitution of receptor for pituitary adenylate cyclase-activating polypeptide. large-scale purification of a functionally active G protein-coupled receptor produced in Sf9 insect cells.
    Ohtaki T; Ogi K; Masuda Y; Mitsuoka K; Fujiyoshi Y; Kitada C; Sawada H; Onda H; Fujino M
    J Biol Chem; 1998 Jun; 273(25):15464-73. PubMed ID: 9624132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
    Miyamoto Y; Habata Y; Ohtaki T; Masuda Y; Ogi K; Onda H; Fujino M
    Biochim Biophys Acta; 1994 Aug; 1218(3):297-307. PubMed ID: 8049255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of pituitary GnRH binding sites by means of a zwitterionic detergent.
    Winiger BP; Birabeau MA; Lang U; Capponi AM; Sizonenko PC; Aubert ML
    Mol Cell Endocrinol; 1983 Jul; 31(1):77-91. PubMed ID: 6309585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of the receptor for pituitary adenylate cyclase-activating polypeptide.
    Ohtaki T; Masuda Y; Ishibashi Y; Kitada C; Arimura A; Fujino M
    J Biol Chem; 1993 Dec; 268(35):26650-7. PubMed ID: 8253796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
    Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Mol Pharmacol; 1992 Aug; 42(2):347-55. PubMed ID: 1325033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
    Gottschall PE; Tatsuno I; Arimura A
    FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of functional calcitonin receptors.
    Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Martin TJ
    Biochem J; 1988 Jul; 253(2):505-10. PubMed ID: 2845921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.